Cover Image
Market Research Report

Sihuan Pharmaceutical Holdings Group Ltd - Product Pipeline Review - 2016

Published by Global Markets Direct Product code 253793
Published Content info 37 Pages
Delivery time: 1-2 business days
Price
Back to Top
Sihuan Pharmaceutical Holdings Group Ltd - Product Pipeline Review - 2016
Published: December 30, 2016 Content info: 37 Pages
Description

Summary:

Global Markets Direct's, 'Sihuan Pharmaceutical Holdings Group Ltd - Product Pipeline Review - 2016', provides an overview of the Sihuan Pharmaceutical Holdings Group Ltd's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sihuan Pharmaceutical Holdings Group Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

  • The report provides a snapshot of the pipeline therapeutic landscape of Sihuan Pharmaceutical Holdings Group Ltd
  • The report provides overview of Sihuan Pharmaceutical Holdings Group Ltd including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Sihuan Pharmaceutical Holdings Group Ltd's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Sihuan Pharmaceutical Holdings Group Ltd's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy:

  • Evaluate Sihuan Pharmaceutical Holdings Group Ltd's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Sihuan Pharmaceutical Holdings Group Ltd
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Sihuan Pharmaceutical Holdings Group Ltd's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Product Code: GMDHC08193CDB

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • Sihuan Pharmaceutical Holdings Group Ltd Snapshot
    • Sihuan Pharmaceutical Holdings Group Ltd Overview
    • Key Facts
  • Sihuan Pharmaceutical Holdings Group Ltd - Research and Development Overview
    • Key Therapeutic Areas
  • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Products Glance
    • Sihuan Pharmaceutical Holdings Group Ltd - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
    • Sihuan Pharmaceutical Holdings Group Ltd - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Sihuan Pharmaceutical Holdings Group Ltd - Early Stage Pipeline Products
      • IND/CTA Filed Products/Combination Treatment Modalities
      • Preclinical Products/Combination Treatment Modalities
    • Sihuan Pharmaceutical Holdings Group Ltd - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Sihuan Pharmaceutical Holdings Group Ltd - Drug Profiles
    • BR-01 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • cinepazide mesylate - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • cyclosporine - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • JK-05 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • levophencynonate hydrochloride - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • pinoxacin hydrochloride - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Analysis
    • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Products by Target
    • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Products by Route of Administration
    • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Products by Molecule Type
    • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Products by Mechanism of Action
  • Sihuan Pharmaceutical Holdings Group Ltd - Dormant Projects
  • Sihuan Pharmaceutical Holdings Group Ltd - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • cyclosporine
  • Sihuan Pharmaceutical Holdings Group Ltd - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Sihuan Pharmaceutical Holdings Group Ltd, Key Facts
  • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Indication, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Stage of Development, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Monotherapy Products in Pipeline, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Partnered Products in Pipeline, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Partnered Products/ Combination Treatment Modalities, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Pre-Registration, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Phase II, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - IND/CTA Filed, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Preclinical, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Unknown, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Target, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Route of Administration, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Molecule Type, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Products by Mechanism of Action, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Dormant Developmental Projects,2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Discontinued Pipeline Products, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd, Subsidiaries

List of Figures

  • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Indication, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Stage of Development, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Monotherapy Products in Pipeline, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Target, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Route of Administration, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Molecule Type, 2016
  • Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Products by Mechanism of Action, 2016
Back to Top